| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 123369-41-5 | Adenosine,N-[(5-hydroxy-2-pyridinyl)methyl]- (9CI); AMG 1; AMG1 (phArmaceutical) |  | C16H18N6O5 | 詳情 | 供應商 | |
| 121808-24-0 | Benzenepropanamide,4-(2,6-dimethylheptyl)-N-(2-hydroxyethyl)-b-methyl-; E5050; E 5050 (phArmaceutical) |  | C21H35NO2 | 詳情 | 供應商 | |
| 148869-05-0 | Benzonitrile,4-[[(4-bromophenyl)methyl]-4H-1,2,4-triazol-4-ylamino]-; YM 511; YM511 (phArmaceutical) |  | C16H12BrN5 | 詳情 | 供應商 | |
| 69542-93-4 | Butanoic acid,4-[(2,2-dimethyl-1-oxopropyl)amino]-; CXB 722; PG2; PG 2 (phArmaceutical); Pivagabine; Tonerg |  | C9H17NO3 | 詳情 | 供應商 | |
| 117347-84-9 | Benzenamine,N,N-dimethyl-2-[[[1-(3-methyl-2-pyridinyl)-1H-imidazol-2-yl]sulfinyl]methyl]-; T 330; T330 (phArmaceutical) |  | C18H20N4OS | 詳情 | 供應商 | |
| 84461-99-4 | Benzamide,N-[2,4-dibromo-6-[(cyclohexylmethylamino)methyl]phenyl]-4-hydroxy-3-methoxy-; BR 227; BR227 (phArmaceutical) |  | C22H26Br2N2O3 | 詳情 | 供應商 | |
| 120377-58-4 | Benzenepropanoic acid, a-[2-[[3-(hydroxyamino)-3-oxo-1-(phenylmethyl)propyl]amino]-2-oxoethyl]-; ST51; ST 51 (phArmaceutical) |  | C21H24N2O5 | 詳情 | 供應商 | |
| 56979-88-5 | Carbamic acid,(aminocarbonyl)(2-chlorophenyl)-, ethyl ester (9CI); SCS 100; SCS 100 (phArmaceutical) |  | C10H11ClN2O3 | 詳情 | 供應商 | |
| 311343-11-0 | Ethanethioic acid,S-[2-[[(2R)-2-(acetylamino)-3-mercapto-1-oxopropyl]amino]ethyl] ester; I 152; I152 (phArmaceutical) |  | C9H16N2O3S2 | 詳情 | 供應商 | |
| 110157-92-1 | Glycine,N,N-bis[2-[2-(4,5-dihydro-2-methyl-5-nitro-1H-imidazol-1-yl)ethoxy]-2-oxoethyl]-(9CI); CM; CM(phArmaceutical); Metronidazolamic acid |  | C18H27N7O10 | 詳情 | 供應商 | |
| 142744-39-6 | Imidazo[1,2-a]pyrazine-2-carbonitrile,6-bromo-8-(methylamino)-; SCA 40; SCA40 (phArmaceutical) |  | C8H6BrN5 | 詳情 | 供應商 | |
| 149847-76-7 | Imidazo[1,2-c]quinazolin-5(3H)-one,2-[[4-(2-chlorophenyl)-1-piperazinyl]methyl]-2,6-dihydro-; CK 53; CK53 (phArmaceutical) |  | C21H22ClN5O | 詳情 | 供應商 | |
| 105384-23-4 | Phosphonic diamide,P-1-aziridinyl-N'-(4-ethoxyphenyl)-N,N-diethyl-; A 506; A506 (phArmaceutical) |  | C14H24N3O2P | 詳情 | 供應商 | |
| 112466-13-4 | Pyrrolo[1,2-a]pyrimidin-4(1H)-one,1-ethyl-7-phenyl-; FPP 129; V33; V 33 (phArmaceutical) |  | C15H14N2O | 詳情 | 供應商 | |
| 105384-20-1 | Phosphonic diamide,P-1-aziridinyl-N,N-diethyl-N'-(4-fluorophenyl)-; A 504; A504 (phArmaceutical) |  | C12H19FN3OP | 詳情 | 供應商 | |
| 121809-80-1 | Propanoic acid,2-[4-[[[(3,5-dichlorophenyl)amino]carbonyl]amino]phenoxy]-2-methyl-; L 35; L 35(phArmaceutical) |  | C17H16Cl2N2O4 | 詳情 | 供應商 | |
| 31518-98-6 | Piperidine,2-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)methyl]-1-methyl-; PF 97; PF97 (phArmaceutical) |  | C22H25N | 詳情 | 供應商 | |
| 52819-82-6 | Phosphinic acid,diphenyl-, 2-[2-(3-pyridinyl)-1-piperidinyl]ethyl ester (9CI); TK 4(phArmaceutical) |  | C24H27N2O2P | 詳情 | 供應商 | |
| 153890-03-0 | Phenol,3,3'-(3,4-dimethyl-2,5-furandiyl)bis[6-methoxy-; GS 01; GS01 (phArmaceutical) |  | C20H20O5 | 詳情 | 供應商 | |
| 183232-66-8 | AM 251 | 1H-Pyrazole-3-carboxamide,1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-1-piperidinyl-; AM 251; AM251 (phArmaceutical) |  | C22H21Cl2IN4O | 詳情 | 供應商 |